Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Multiple locations, including Hartford
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Multiple locations, including HartfordThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on bipolarity and currently lists participation information in Norway.
In TrondheimThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom, France, Germany, Ireland, Italy, and the United States.
In United KingdomThis study is recruiting. It focuses on bipolarity and currently lists participation information in Canada.
Multiple locations, including HamiltonThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Malaysia.
In MalaysiaThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
In TulsaThis study is recruiting in Australia. It is testing CADET candesartan trial for depression in bipolarity.
In AustraliaThis study is recruiting in the United Kingdom. It focuses on Bipolarity.
In United KingdomThis study is recruiting in the United States. It focuses on Bipolarity.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.